EP2423331
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.3.2005EP published:
8.5.2019EP application number:
11178200.9
EPO information:
European Patent Register
Max expiry date:
30.3.2025
Title:
Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
Timeline
Today
31.3.2005EP application
8.5.2019EP Publication
Owner
Name:
The General Hospital CorporationAddress:
55 Fruit Street, 02114, Boston, MA, US
Name:
Dana-Farber Cancer Institute, Inc.Address:
450 Brookline Avenue, 02215, Boston, MA, US
Inventor
Name:
Bell, Daphne WinifredAddress:
Chevy Chase, MD, US
Name:
Haber, Daniel A.Address:
Chestnut Hill, MA, US
Name:
Janne, Pasi AnteroAddress:
Newton, MA, US
Name:
Johnson, Bruce E.Address:
Brookline, MA, US
Name:
Lynch, Thomas J.Address:
New Haven, CT, US
Name:
Meyerson, MatthewAddress:
Concord, MA, US
Name:
Paez, Juan GuillermoAddress:
Boston, MA, US
Name:
Sellers, William R.Address:
Brookline, MA, US
Name:
Settleman, Jeffrey E.Address:
Mill Valley, CA, US
Name:
Sordella, RaffaellaAddress:
Syosset, NY, US
Priority
Number:
558218 PDate:
31.3.2004Country:
US
Number:
561095 PDate:
9.4.2004Country:
US
Number:
565753 PDate:
27.4.2004Country:
US
Number:
565985 PDate:
27.4.2004Country:
US
Number:
574035 PDate:
25.5.2004Country:
US
Number:
577916 PDate:
7.6.2004Country:
US
Number:
592287 PDate:
29.7.2004Country:
US
Classification
Categories:
C12Q 1/68, C07H 21/04